Key statistics
As of last trade Neuraxis Inc (NRXS:ASQ) traded at 4.56, -26.53% below its 52-week high of 6.20, set on May 20, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 4.68 |
|---|---|
| High | 4.80 |
| Low | 4.53 |
| Bid | 4.50 |
| Offer | 4.61 |
| Previous close | 4.62 |
| Average volume | 55.45k |
|---|---|
| Shares outstanding | 10.65m |
| Free float | 8.60m |
| P/E (TTM) | -- |
| Market cap | 49.22m USD |
| EPS (TTM) | -1.02 USD |
Data delayed at least 15 minutes, as of Feb 11 2026 16:50 GMT.
More ▼
- NeurAxis Achieves Major Milestone with AMA Category I CPT® Code Now in Effect, Establishing a Permanent Reimbursement Pathway
- NeurAxis Achieves Medical Coverage Policy Milestone, Expanding Access to Approximately 45 million additional Covered Lives
- NeurAxis Secures Veterans Affairs Federal Supply Schedule Contract, Broadening Access to More Patients with Functional Abdominal Pain
- NeurAxis Announces New Medical Policy Coverage in Michigan, Adding 566,000 Covered Lives
- NeurAxis Reports Strong Third Quarter 2025 Financial Results Driven by a 22% Growth in Revenues
- NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
- NeurAxis Awarded First Ever FDA Clearance for the Treatment of Pain in Functional Dyspepsia (FD) with associated Nausea Symptoms in the Adult Patient Population
- NeurAxis Reports Strong Second Quarter 2025 Financial Results Driven by a 46% Growth in Revenues
- NeurAxis to Host Second Quarter 2025 Results and Business Update Call on Tuesday, August 12, 2025
- NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives
More ▼
